Drew Moghanaki, Professor, Chief of Thoracic Oncology at the Department of Radiation Oncology and Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at David Geffen School of Medicine at UCLA, and Chief Medical Officer of Respirati, shared a post on LinkedIn:
“A non-scientific post on X/Twitter confirms what I suspected. Many people in the radiation oncology field are unaware of the harm that 4DCT artifacts, akin to hallucinations, are introducing in our treatment designs.
The medical physics community is keenly aware of this problem, yet few MDs know about it or discuss it publicly. It’s a matter of treatment efficacy vs failure as demonstrated in this German report, which is one of many documenting the need to find a replacement solution.”
Title: 4D CT image artifacts affect local control in SBRT of lung and liver metastases
Authors: Thilo Sentkera, Vladimir Schmidt, Ann-Kathrin Ozgab, Cordula Petersen, Frederic Madesta, Christian Hofmann, René Werner, Tobias Gauer
You can read the full article in Radiotherapy and Oncology.
More posts featuring Drew Moghanaki.